Align Technology price target lowered to $215 from $240 at UBS

UBS lowered the firm’s price target on Align Technology (ALGN) to $215 from $240 and keeps a Neutral rating on the shares. While macro concerns are weighing on the stock, increased financing options may drive upside, the analyst tells investors in a research note. The company’s May 6 investor day presents a catalyst for the management team to reshape the narrative, set a new, and more realistic, long-term target, and detail the contribution and market opportunity for new offerings, UBS says.